Advertisement

Membrane Requirements in the Pursuit of Blood Oxygenator Optimization

  • Wilfred F. Mathewson
  • David M. Ryon

Abstract

Until recently, clinical use of blood oxygenators has been restricted to direct contacting devices, in which the blood has a direct interface with oxygen. This is most commonly accomplished by either passing bubbles of oxygen through a continuous phase of blood or filming the blood and allowing oxygen to contact the free surface. In both cases, addition of oxygen and removal of carbon dioxide from the blood is readily achieved. However, the high surface energies present at the gas/blood interface causes excessive blood trauma in the form of hemolysis and protein denaturation.(1) This limits such devices to short term heart/lung bypass such as open heart surgery where only several hours of perfusion are required. If clinical applications are to be enlarged to include intermediate and long term support for coronary diseases and pulmonary insufficiency, then means must be found to reduce blood trauma to acceptable physiological levels. Hopefully, this will be the role of the membrane lung.

Keywords

Oxygen Transfer Blood Flow Rate Blood Film Membrane Envelope Membrane Lung 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gollub, S. and Bailey, C.P., JAMA, 198, p. 1171, (1966).PubMedCrossRefGoogle Scholar
  2. 2.
    Peirce II, E.C., “The Membrane Lung - Its Excuse, Present Status and Promise”, Journal of the Mount Sinai Hospital, 34, No. 5, (Sept. 1967).Google Scholar
  3. 3.
    Peirce II, E.C., et al, Trans. Am. Soc. Artificial Internal Organs, 15, pp. 33–38, (1969).Google Scholar
  4. 4.
    Peirce II, E.C., Trans. Am. Soc. Artificial Internal Organs, 16, (1970).Google Scholar
  5. 5.
    Guyton, A.G., Textbook of Medical Physiology pp. 574–578, W.F. Saunders, Philadelphia, (1968).Google Scholar
  6. 6.
    Mason, R.G., et al, National Institutes of Health–Artificial Heart Program Conference Proceedings, pp. 193–202, (1969).Google Scholar
  7. 7.
    Peirce, E.C. and Mathewson, W.F., National Institutes of Health–Artificial Heart Program Conference Proceedings, pp. 405–416, (1969).Google Scholar
  8. 8.
    Bird, R.B., et al, Transport Phenomena, pp. 349–370, John Wiley & Son, New York, (1960).Google Scholar
  9. 9.
    Hastings, A.B. and Singer R.B., Medicine, 27, No. 2, pp. 223–243, (May 1948).PubMedCrossRefGoogle Scholar
  10. 10.
    Weissman, M.H. and Mockros, L.F., Med. & Bio. Eng., 7, pp. 169–184, (1969).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1971

Authors and Affiliations

  • Wilfred F. Mathewson
    • 1
  • David M. Ryon
    • 1
  1. 1.Medical Development OperationGeneral Electric CompanyUSA

Personalised recommendations